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Abstract
The transcription factor Oct4 is well defined as a key regulator of embryonic stem (ES) cell pluripotency. In recent
years, the role of Oct4 has purportedly extended to the self renewal and maintenance of multipotency in adult
stem cell (ASC) populations. This profile has arisen mainly from reports utilising reverse transcription-polymerase
chain reaction (RT-PCR) based methodologies and has since come under scrutiny following the discovery that
many developmental genes have multiple pseudogenes associated with them. Six known pseudogenes exist for
Oct4, all of which exhibit very high sequence homology (three >97%), and for this reason the generation of arte-
facts may have contributed to false identification of Oct4 in somatic cell populations. While ASC lack a molecular
blueprint of transcription factors proposed to be involved with ‘stemness’ as described for ES cells, it is not unrea-
sonable to assume that similar gene patterns may exist. The focus of this work was to corroborate reports that
Oct4 is involved in the regulation of ASC self-renewal and differentiation, using a combination of methodologies to
rule out pseudogene interference. Haematopoietic stem cells (HSC) derived from human umbilical cord blood
(UCB) and various differentiated cell lines underwent RT-PCR, product sequencing and transfection studies using an
Oct4 promoter-driven reporter. In summary, only the positive control expressed Oct4, with all other cell types
expressing a variety of Oct4 pseudogenes. Somatic cells were incapable of utilising an exogenous Oct4 promoter
construct, leading to the conclusion that Oct4 does not appear involved in the multipotency of human HSC from
UCB.
Introduction
Octamer binding protein 4 (Oct4, also known as Pou5f1
and Oct3) is the transcription factor most associated
with and critical for maintenance of totipotency in blas-
tomeres and pluripotency in the inner cell mass of
developing mammalian embryos [1,2]. Belonging to the
POU domain family of transcription factors [2], Oct4
mediates activation or repression of target genes
involved in stem cell differentiation, either as a dimeric
trans-activator of gene expression or synergistically with
other transcription factors such as Sox2 [3]. Until
recently, Oct4 was thought to be expressed exclusively
in embryonic stem (ES) cells and primordial germ cells.
Several recent studies have proposed however, that Oct4
may also regulate adult stem cell multipotency, with
expression detected in a variety of tissues including:
bone marrow, peripheral blood and umbilical cord
blood (UCB) derived cells [4-9], human progenitor-like
cells from liver [10], skin epidermis [11] and hair folli-
cles [12]. While the prospect of such genes being
involved in somatic stem cell self-renewal and differen-
tiation is appealing, caution is necessary following the
discovery that some developmental genes have multiple
pseudogenes [13].
Mammalian genomes contain many gene-like
sequences which appear similar to functional genes,
but which contain defects that either prevent transcrip-
tion or generate non-functional protein transcripts. A
duplicated pseudogene often lacks regulatory regions
[14] and may arise from gene duplication or unequal
crossing-over during meiosis and can retain some
intron/exon boundaries observed in the parental gene.
Alternatively, processed pseudogenes or retro-transpo-
sons represent the mRNA form of the gene rather than
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promoter sequences. The belief is that mRNA is con-
verted into DNA via a reverse transcriptase event and
randomly inserted back into t h eg e n o m e[ 1 5 ] .I fi n s e r -
tion places the pseudogene under the influence of a
nearby active promoter, it may consequently be
expressed. As with duplicated pseudogenes, accumula-
tion of DNA mutations prevents coding of functional
proteins. Nonetheless, evidence suggests that some
pseudogene transcripts may play regulatory roles in
expression of the parental gene, potentially by an RNA
interference-like mechanism [16-19]. Hence some
pseudogenes are transcribed and as such may generate
false positives in hybridisation or amplification
experiments.
Experimental prudence is therefore advisable due to
the high sequence homology between developmental
genes and their pseudogene transcripts. At present, Oct4
has six known pseudogenes, all having a minimum of
84.7% sequence identity with genuine Oct4,t h r e eo f
which have >97% [19]. Similarly for other developmen-
tally important genes such as Nanog and Stella, numer-
ous pseudogenes with coding regions containing >90%
sequence conservation have been identified [13]. Many
studies to date have relied on RT-PCR alone as method
of detecting Oct4 in adult stem cells, with few including
other molecular techniques. In the present study, our
aims were to corroborate reports that developmental
genes such as Oct4 are involved in regulation of multi-
potency in human adult progenitor cells, using a combi-
nation of methodologies. Haematopoietic stem cells
derived from human UCB underwent RT-PCR analysis
using primers reported to preclude pseudogene amplifi-
cation, followed by product sequencing. Additionally,
transfection studies utilising a human Oct4 promoter
construct [20], determined whether cells were capable of
expressing the factors necessary for genuine Oct4 gene
expression.
Results
Following recent reports of Oct4 expression in various
adult stem cell populations [4-12], we examined whether
human c-kit
+ HSCs from UCB were also capable of
expressing this early developmental gene, using RT-
PCR, sequencing and transfection studies. Initial RT-
PCR results using Oct4 primer set 1 [21], suggested that
both freshly isolated and cultured c-kit
+ cells expressed
Oct4 (figure 1A). At the time this work was undertaken
however, two reports highlighted evidence that ES cell
genes involved in pluripotency appeared to have a high
proportion of pseudogene expression associated with
them [13,22]. With this in mind, PCR was repeated
using differentiated cell types and cell lines not antici-
pated to express Oct4. The predicted Oct4 transcript
size of 577 base pairs (bp) was generated in normal and
diseased hepatocytes, as well as in cell lines HepG2,
Hek293T and HMC-1 (figure 1A). These results sug-
gested the possibility of pseudogene amplification. Using
NCBI BLAST software, various published Oct4 primer
sequences [10,11,21,23,24] were checked and found to
align with at least one known pseudogene, in addition
to the genuine Oct4 transcript (data not shown). With
Oct4 having 6 highly homologous retro-transposons
already identified (three of which having >97% sequence
homology), designing primers capable of recognising
only genuine Oct4 transcripts proved to be a challenge.
Subsequently, primers described to preclude the amplifi-
cation of Oct4 pseudogenes were published [25] and
RT-PCR analysis repeated. A band of predicted size (647
bp) was generated using primer set 2 in the positive
control (embryonic carcinoma (EC) 2102Ep cells) and c-
kit
+ progenitor cells (figure 1C). As before however, the
cell lines HepG2, Hek293T and HMC-1 also appeared
to amplify an Oct4 transcript (data not shown).
Sequencing of the PCR products amplified by primer
set 2 revealed which cell types were capable of expres-
s i n gg e n u i n eO c t4 .As u m m a r yo ft h es e q u e n c i n gd a t a
Figure 1 RT-PCR analysis of Oct4. A) Expression of Oct4 (Primer set 1, 577 bp) in freshly isolated c-kit
+ haematopoietic cells (T0) and following
culture (T3–T10); EC 2102Ep cells (+ control); water (- control); normal hepatocytes (NL); diseased hepatocytes (DL); HepG2 cells; Hek293T cells
(Hek); human mast cell line (HMC1). B) b-actin controls (245 bp). C) Expression of Oct4 (Primer set 2, 647 bp) in c-kit
+ cells (T0-T10); EC 2102Ep (+
control); water (-).
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control cells (EC 2102Ep) aligned 100% against the
NCBI BLAST sequence of Oct4 (figure 2 and table 1).
Results obtained for both freshly isolated and cultured
c-kit
+ cells illustrated the high level of homology
between the c-kit
+ cell transcripts and the Oct4
sequence (figure 2, 97.6%), however ~14 base pair mis-
matches indicated the probability of pseudogene amplifi-
cation. Comparison of PCR-amplified cDNA from c-kit
+
cells with known Oct4 retro-transposon sequences con-
firmed that at least three pseudogenes were being
expressed in the HSCs (table 1). These pseudogene
alignments ranged from 99.5 - 99.8% sequence homol-
ogy and were found on chromosomes 1, 10 and 12.
Oct4 products generated in cell lines HepG2 and
Hek293T also aligned with pseudogenes from chromo-
some 1 and 12 with 99% and 99.5% homology respec-
tively (table 1).
Transfection studies were used as an alternative means
to determine whether c-kit
+ progenitor cells expressed
the transcription factors necessary to activate Oct4 gene
expression. Freshly isolated c-kit
+ cells were rested over-
night in expansion media before electroporation. At 48
h post-transfection, the only progenitor cell samples
expressing GFP were the two positive controls, pMAX-
EGFP (figure 3A) and pC1-EGFP (data not shown).
C-kit
+ cells transfected with an Oct4 promoter driven
construct phOCT3-EGFP1, were negative for GFP
expression (figure 3B). The low level of non specific
auto-fluorescence seen for c-kit
+ cells transfected with
phOCT3-EGFP1 was comparable to the no vector nega-
tive control (figure 3C). Although comparison of fluor-
escence and phase contrast light microscopy illustrated
the low level of transfection efficiency with control vec-
tors (approximately 30% for pMAX-EGFP), this did con-
firm c-kit
+ progenitor cells were capable of expressing
exogenous GFP (figure 3A). Similar results were
o b s e r v e dw i t hc u l t u r e dc - k i t
+ cells (transfected 11-14
days expansion), with the difference that fewer cells
appeared to express GFP in both controls (data not
shown). Transfection of the cell lines HepG2 and
Hek293T generated similar results to those for c-kit
+
cells, both with pEGFP-C1 vector and phOCT3-EGFP1,
in that none appeared capable of Oct4 driven GFP
expression (data not shown). The only cell type to exhi-
bit Oct4 promoter driven fluorescence was the cell line
EC 2102Ep (figure 3D).
Discussion
At present the molecular mechanisms involved in adult
stem cell pluripotency and self renewal remain largely
unknown. Furthermore, they appear to lack a blueprint
of transcription factors proposed to be involved with
‘stemness’, as described for ES cells [26]. It is not unrea-
sonable to assume however, that similar gene patterns
may exist for adult stem cells. The focus of this work
was to ascertain whether human adult stem cells, speci-
fically c-kit isolated cells from UCB were capable of
expressing transcription factors described for ES cell
pluripotency. The impetus for the study arose over con-
troversy following the number of recent reports suggest-
ing genes such as Oct4 play a role in regulation of adult
stem cell multipotency [4-12] and the proposed pre-dis-
position of developmentally active genes to retro-trans-
position events [13].
From our initial results, it became clear that reliance
on RT-PCR technology was highly dependent on the
specificity of primer sequences and was an unreliable
method of analysing ES cell pluripotency genes in adult
stem cells. Amplification of ‘Oct4’ transcripts in differ-
entiated cell types such as hepatocytes and various cell
lines (together with c-kit
+ progenitor cell populations),
revealed the difficulty in designing primers capable of
recognising only genuine Oct4.O ne x a m i n a t i o no fs e v -
eral published primer sequences, all aligned with Oct4
pseudogene sequences in addition to genuine Oct4,a s
determined using the NCBI BLAST alignment tool
[10,11,21,23,24]. This raised the possibility that artefacts
generated by Oct4 pseudogenes may have contributed to
false identification of Oct4 and our current knowledge
of adult stem cell gene expression. Recently, Liedtke et
al [27] approached this problem by alignment of Oct4
to all its known pseudogene sequences with design of
exact primers incorporating a polymorphism unique to
genuine Oct4. They demonstrated that their primers
could discriminate between cDNA and genomic DNA.
Table 1 Summary of Oct4 sequencing data.
Oct4 Chromosome 6 Pseudogene Chromosome 1 Pseudogene Chromosome 10 Pseudogene Chromosome 12
C-kit+ T0 No Yes Yes -
C-Kit+ T7 No - Yes Yes
EC 2102Ep Yes - - -
Hek293T No - - Yes
HepG2 No Yes - -
Expression of Oct4 was observed in EC 2102Ep cells (+ control). All other cells expressed a variety of Oct4 pseudogene transcripts derived from chromosomes 1,
10 and 12. C-kit
+ cells (T0) n = 7, c-kit
+ cells (T7) n = 4, all other cell types n = 3.
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Page 3 of 8Figure 2 Oct4 sequence alignments. Alignment of Oct4 mRNA and pseudogene sequence from chromosome 1, with putative Oct4 RT-PCR
sequenced products from freshly isolated c-kit
+ cells (T0) and EC 2102Ep cells (+ control). The solid grey background indicates sequence
homology, with base pair mismatches highlighted by white background. Black boxes indicate homology between c-kit
+ and pseudogene
sequences and disparity with Oct4. White letters on grey background denote primer positions.
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[27] showed that Oct4 was not expressed in human cord
blood mononuclear (MN) cells or peripheral blood MN
cells, contradicting other recent reports [5,7,28].
In both ES and EC cell types, pseudogene expression
appears less of a contaminating factor in such cell popu-
lations. This may be attributed to events which occur
during early development, whereby genes which are not
involved in embryonic patterning are silenced by pro-
moter methylation. Genes such as Oct4 have an ‘anti-
silencing’ promoter which prevents methylation during
this stage of embryonic development [29]. Hence, lack
of pseudogene expression in these cells may likely be
due to such generic gene silencing. Our sequencing
results however, suggest that neither freshly isolated nor
cultured c-kit
+ progenitor cells (nor cell lines HepG2,
Hek293T and HMC1) undergo such tight regulation of
Oct4 pseudogene expression, whilst they also appear to
be incapable of genuine Oct4 transcription. The reason
why the frequency of retro-transposition events in ES
cell-specific genes far exceeds those of non-ES cells is
not known [13]. Interestingly, this may have particular
significance with regard to recent findings by Elliman et
al [30] who have detected pseudogene expression of
Dppa3/Stella in human adult tissue types including
bone marrow, peripheral blood, pancreas, adrenal and
thyroid gland. This supports the fact that developmental
pseudogene expression in differentiated tissues is more
widespread than previously thought and reiterates the
need for caution regarding use of such genes as markers
of adult stem cell pluripotency.
Our subsequent strategy was to select published pri-
mers designed to specifically amplify genuine Oct4 gene
expression [25]. Unfortunately, our sequencing results
confirmed that in non ES cell samples, these too
detected pseudogene expression. On inspection of where
these primers aligned on genomic DNA from chromo-
some 6, the reason why they may have failed to preclude
pseudogene amplification became apparent. The anti-
s e n s ep r i m e rs e q u e n c et a k e nf r o mP i c k e r i n get al [25]
had not incorporated an additional guanine base present
in the Oct4 sequence obtained from NCBI, accession
number NC_000006. Subsequent ‘BLASTing’ with the
new primer sequence generated alignments to several
pseudogene transcripts, thus providing an explanation
for our unexpected RT-PCR false positives. (NB: the
Oct4 DNA sequence used to identify primer sequences
was NCBI version GI:51511722 which replaced version
GI:42406225 on 24 august 2004). Therefore, it is possi-
ble that the previous DNA sequence had omitted the
guanine base identified and may have influenced original
primer design. Our sequencing results revealed that only
the EC cell positive control expressed the genuine Oct4
transcript with 100% sequence homology to the 647 bp
product. All the other cell types examined expressed a
selection of the various Oct4 pseudogene mRNAs found
on chromosomes 1,10 and 12, all which have >97%
homology to genuine Oct4 [19].
Figure 3 Transfection studies on freshly isolated c-kit
+ cells. Freshly isolated c-kit
+ cells transfected with: A) positive control vector pMAX-
EGFP; B) phOCT3-EGFP; C) No vector negative control; D) EC 2102Ep cells transfected with phOCT3-EGFP. Lower panel represents phase contrast
images of the above GFP images. Original magnification 100× (A, B, C) and 200× (D). Scale bar 50 μM.
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gene transcripts may act as regulators of protein synth-
esis and mRNA stability, particularly during
carcinogenesis [31,18,19]. Kandouz et al [18] revealed
that a Connexin43 pseudogene [ψCx43] plays a func-
tional role in some tumour cells. The protein Con-
nexin43, involved in intercellular communication is
often deregulated in many cancers. Interestingly, in
some cancer cells ψCx43 becomes translated into a
functional protein, playing a role in growth inhibition.
This appears to contradict the common concept that
pseudogenes represent a version of a gene mutated to
inactivity. If however, the mutation is within a regula-
tory region which prevents transcription, perhaps under
certain cellular conditions the pseudogene may be
expressed. This putative role of Oct4 pseudogene tran-
scripts in regulation of the parent gene has been pro-
posed by Suo et al [19] who identified two pseudogenes
transcribed in conjunction with the apparent genuine
Oct4 in HepG2, MCF-7 and Hela cell lines. Neverthe-
less, this is speculative and recent work by Mueller et al
[32], using a variety of techniques and in excess of 30
somatic tumour cell lines, have concluded that func-
tional Oct4 is not expressed. As with our results, they
also demonstrated that the only cells to exhibit genuine
Oct4 expression were EC cell lines [32].
Although sequencing data in the present study
revealed no genuine Oct4 expression in c-kit
+ cells, we
wished to investigate whether these cells were capable
of utilising an exogenous Oct4 promoter construct. The
reasoning was that if levels of pseudogene transcripts
were relatively high in comparison to their genuine Oct4
counterparts, the pseudogenes may have been preferen-
tially amplified. Our results corroborated the sequencing
data in that the only cells able to express genuine Oct4
were the EC 2102Ep cells, with no GFP observed in
c-kit
+ HSCs or cell lines HepG2 and Hek203T. In sum-
mary our results suggest that Oct4 does not appear to
be involved in adult stem cell multipotency, in human
UCB progenitor cells. In support of our findings, work
by Lengner et al [33] have shown recently the same
appears true for a variety of mouse somatic stem cells,
using Oct4 gene ablation. They show that Oct4 is dis-
pensable for self-renewal in intestinal epithelium, bone
marrow mesenchymal stem cells and HSC, hair follicle,
brain and liver in contrast with previous findings utilis-
ing mainly RT-PCR analysis.
In conclusion, together with a number of recent
reports [27,32,34,35] on the controversy surrounding the
role of Oct4 in ASCs, our study has underlined the
necessity of utilising more than one approach to identify
embryonic genes involved in pluripotency before
hypothesising their involvement in ASC multipotency.
We were unable to substantiate recent reports that Oct4
is involved in the self-renewal of somatic stem cell
populations, reiterating the need for caution in the
interpretation of results, especially RNA derived when




Human Adult Stem Cells
UCB was collected following local ethics committee
approved informed consent from women undergoing
full-term elective caesarean sections at Birmingham
Women’s Hospital. Freshly isolated blood was treated
with 10% sodium citrate solution to prevent clotting and
the mononuclear fraction of cells isolated using a
sucrose density gradient (Ficoll-Paque™,U K ) .C o n t a m i -
nating red blood cells were depleted by ammonium
chloride treatment, followed by purification of a c-kit
+
progenitor cell population using positive immuno-selec-
tion (EasySep™ Technique, StemCell Technologies Inc,
UK: CD117/c-kit R-PE IgG1,c l o n eY B 5 . B 8 ,B DP h a r -
Mingen Biosciences, UK). The percentage yield and pur-
ity of isolated cells was ascertained by flow cytometry:
the mononuclear cell fraction consisted of 4% c-kit
+
cells, which following isolation using EasySep™,g a v ea
c-kit
+ population of 89% purity (data not shown). Pro-
genitor cells were maintained in suspension, in Stem
Span™ serum free media with addition of 100 ng/ml
stem cell factor (SCF), 10 ng/ml flt-3 ligand, 10 ng/ml
thrombopoietin and 2 mM L-glutamine (Stem Cell
Technologies Inc, UK). Cells were plated at a density
of ~2 × 10
5 cell/ml and media changed every 4-5 days.
Human Cell Lines
The embryonic carcinoma (EC) cell line 2102Ep (kindly
provided by Prof PW Andrews, University of Sheffield)
w a sc u l t u r e do np l a s t i c ,i nD M E Ms u p p l e m e n t e dw i t h
10% foetal calf serum (FCS) and 2 mM L-glutamine.
The human derived cell lines HepG2, human embryonic
kidney Hek293T and human mast cell HMC-1 were
routinely cultured in DMEM supplemented with 10%
FCS, 2 mM L-glutamine, 1 mM sodium pyruvate, 1%
nonessential amino acids and 1% penicillin/streptomy-
cin. Media was changed every other day and all cells
were maintained at 37°C in a humidified atmosphere of
5% CO2 in air.
RT-PCR Analysis of Gene Expression
Total RNA was extracted from freshly isolated and cul-
tured c-kit
+ UCB cells and cell line pellets using Rnazol
(BioGenesis, UK, 1 ml/~10
8 cells) and chloroform (200
μl/~10
8 cells). Following agitation, incubation on ice and
centrifugation (6000 g, 15 min), the aqueous phase was
removed and added to an equal volume of isopropanol
a n ds t o r e do v e r n i g h ta t4 ° C .Samples were centrifuged
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washed in 75% (v/v) ethanol. The final RNA pellet was
then resuspended in 10 μl PCR water (Sigma-Aldrich
Co. UK) and contaminating genomic DNA removed fol-
lowing treatment with DnaseI (Amersham Biosciences,
UK). RNA samples were stored at -80°C.
cDNA was generated from mRNA under standard
conditions using 100 μM random hexamers, 10 mM
dNTPs (Amersham Biosciences) 50 mM MgCl2, 10×
PCR buffer (Invitrogen), 50 mM Rnasin® ribonuclease
inhibitor (Promega, UK) and superscript II. cDNA sam-
ples were stored at -20°C. The polymerase chain reac-
tion contained 10× PCR buffer, 50 mM MgCl2,1 0m M
of each dNTP, 25 μM primers, PCR water and Taq
DNA polymerase. The PCR primers used for amplifying
Oct4 were those reported by Henderson et al [21] (set 1)
and Pickering et al [25] (set 2). Oct4 primer set 1:
forward 5’ CGACCATCTGCCGCTTTGAG 3’, reverse 5’
CCCCCTGTCCCCCATTCCTA 3’;O c t 4p r i m e rs e t2 :
forward 5’ GAAGGTATTCAGCCAAAC 3’,r e v e r s e5 ’
CTTAATCCAAAAACCCTGG 3’. b-actin forward 5’
CATCACCATTGGCAATGAGC 3’,r e v e r s e5 ’ CGATC-
CACACGGAGTACTTG 3’. The PCR cycling parameters
used for each primer set consisted of an initial cDNA
denaturation of 3 min at 94°C, followed by a cycle of 1
min at 94°C, 1 min at annealing temperature and DNA
extension for 1 min at 72°C. Generally, the number of
amplification cycles was 30-35 maximum. A final exten-
sion step was performed at 72°C for 10 min and held at
4°C until analysis. All experiments included negative con-
trols with no cDNA added. PCR products were resolved
by 1% agarose gel electrophoresis and visualised using
ethidium bromide staining. Oct4 RT-PCR products were
confirmed by sequencing.
DNA Sequencing
Amplified DNA was extracted from PCR gels using
QIAEX II kit (as described by the manufacturer, Qiagen,
UK). Purified DNA was sub-cloned into a pGEM®-T
Easy Vector (Promega), followed by heat shock transfor-
mation of JM109 competent cells. Amplified vector was
recovered using QIAGEN Maxiprep and DNA
sequenced at a final concentration of 400 ng/sample via
Plasmid to Profile, version 3 (Genomics Lab, The Uni-
versity of Birmingham). DNA analysis was performed
using FinchTV version 1.4 (
© Geospiza Inc), GeneDoc
(
© 1996-2000 Karl Nicholas) software programs and
NCBI BLAST.
Cell Transfections
Transfection of adherent cell lines was performed using
Lipofectamine™ 2000 (Invitrogen, UK) and for primary
progenitor cells cultured in suspension, cells underwent
transfection by Amaxa electroporation (program U-08,
Amaxa Biosystems, UK), both according to manufac-
turer guidelines. Adherent cells were grown in 25 cm
2
flasks and harvested by trypsinisation at approximately
80 - 95% confluence following 24 hr culture in antibiotic
free media. Progenitor cells were transfected within 24 h
of isolation and following culture up to day 14. Due to
low cell numbers, progenitor cells were transfected at
the lower end of the recommended range at a final con-
centration of 2 × 10
5 cells/100 μl. The 8068 bp Oct4
vector [20] consisted of the human Oct4 promoter
region cloned into an enhanced GFP expressing plasmid
(kindly donated by Dr W Cui, The Roslin Institute,
Edinburgh). Positive control vectors pEGFP-C1 (4731
bp, GenBank, UK) and pMax-GFP (3486 bp, Amaxa
Biosystems), were used to test transfection efficiency for
both systems.
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